Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 1.00% Nasdaq Up 1.29%
Streaming
Ticker Tape: On

Geron Corporation (GERN)

-NasdaqGS
1.97 Up 0.11(5.91%) Apr 16, 4:00PM EDT
|After Hours : 1.95 Down 0.02 (1.02%) Apr 16, 7:12PM EDT
Get the big picture on all your investments.
Prev Close:1.86
Open:1.88
Bid:1.95 x 4200
Ask:1.98 x 2000
1y Target Est:2.00
Beta:2.46
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.85 - 1.98
52wk Range:1.01 - 7.79
Volume:3,054,524
Avg Vol (3m):6,543,490
Market Cap:309.09M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GERN

Comparison

Symbol% ChgMkt Cap
GERNUp 5.91%309.09M
BMYUp 1.95%81.04B
GSKUp 0.96%126.53B
NVSUp 0.74%204.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):227.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Mar-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback